United Therapeutics Insider Sold Shares Worth $5,173,660, According to a Recent SEC Filing
Martine A Rothblatt, Director, Chairperson & CEO, on July 10, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,173,660. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.